BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 26085154)

  • 1. Partial Attenuation of Respiratory Syncytial Virus with a Deletion of a Small Hydrophobic Gene Is Associated with Elevated Interleukin-1β Responses.
    Russell RF; McDonald JU; Ivanova M; Zhong Z; Bukreyev A; Tregoning JS
    J Virol; 2015 Sep; 89(17):8974-81. PubMed ID: 26085154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats.
    Rostad CA; Stobart CC; Gilbert BE; Pickles RJ; Hotard AL; Meng J; Blanco JCG; Moin SM; Graham BS; Piedra PA; Moore ML
    J Virol; 2016 Aug; 90(16):7508-7518. PubMed ID: 27279612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves.
    Taylor G; Wyld S; Valarcher JF; Guzman E; Thom M; Widdison S; Buchholz UJ
    J Gen Virol; 2014 Jun; 95(Pt 6):1244-1254. PubMed ID: 24700100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Small Hydrophobic Protein of J Paramyxovirus in Virulence.
    Abraham M; Arroyo-Diaz NM; Li Z; Zengel J; Sakamoto K; He B
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants.
    Karron RA; Wright PF; Belshe RB; Thumar B; Casey R; Newman F; Polack FP; Randolph VB; Deatly A; Hackell J; Gruber W; Murphy BR; Collins PL
    J Infect Dis; 2005 Apr; 191(7):1093-104. PubMed ID: 15747245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of truncated G protein delivered by live attenuated Salmonella as a vaccine against respiratory syncytial virus.
    Tian P; Xu D; Huang Z; Meng F; Fu J; Wei H; Chen T
    Microb Pathog; 2018 Feb; 115():299-303. PubMed ID: 29306006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines.
    Crowe JE; Firestone CY; Murphy BR
    J Immunol; 2001 Oct; 167(7):3910-8. PubMed ID: 11564809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host proteome correlates of vaccine-mediated enhanced disease in a mouse model of respiratory syncytial virus infection.
    van Diepen A; Brand HK; de Waal L; Bijl M; Jong VL; Kuiken T; van Amerongen G; van den Ham HJ; Eijkemans MJ; Osterhaus AD; Hermans PW; Andeweg AC
    J Virol; 2015 May; 89(9):5022-31. PubMed ID: 25694607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refining the balance of attenuation and immunogenicity of respiratory syncytial virus by targeted codon deoptimization of virulence genes.
    Meng J; Lee S; Hotard AL; Moore ML
    mBio; 2014 Sep; 5(5):e01704-14. PubMed ID: 25249281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B Virus Core Particles Containing a Conserved Region of the G Protein Combined with Interleukin-35 Protected Mice against Respiratory Syncytial Virus Infection without Vaccine-Enhanced Immunopathology.
    Yang J; Ma C; Zhao Y; Fan A; Zou X; Pan Z
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engystol reduces onset of experimental respiratory syncytial virus-induced respiratory inflammation in mice by modulating macrophage phagocytic capacity.
    Wronski S; Dannenmaier J; Schild S; Macke O; Müller L; Burmeister Y; Seilheimer B; Müller M
    PLoS One; 2018; 13(4):e0195822. PubMed ID: 29672626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge.
    Johnson TR; Parker RA; Johnson JE; Graham BS
    J Immunol; 2003 Feb; 170(4):2037-45. PubMed ID: 12574374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
    Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
    J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate and adaptive cellular phenotypes contributing to pulmonary disease in mice after respiratory syncytial virus immunization and infection.
    Lee YT; Kim KH; Hwang HS; Lee Y; Kwon YM; Ko EJ; Jung YJ; Lee YN; Kim MC; Kang SM
    Virology; 2015 Nov; 485():36-46. PubMed ID: 26196232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells.
    Harker JA; Godlee A; Wahlsten JL; Lee DC; Thorne LG; Sawant D; Tregoning JS; Caspi RR; Bukreyev A; Collins PL; Openshaw PJ
    J Virol; 2010 Apr; 84(8):4073-82. PubMed ID: 20130064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of cytokines by recombinant virus in early life alters the immune response to adult lung infection.
    Harker JA; Lee DC; Yamaguchi Y; Wang B; Bukreyev A; Collins PL; Tregoning JS; Openshaw PJ
    J Virol; 2010 May; 84(10):5294-302. PubMed ID: 20200251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Safety and Immune Efficacy of Recombinant Human Respiratory Syncytial Virus Strain Long Live Attenuated Vaccine Candidates.
    Wang LN; Peng XL; Xu M; Zheng YB; Jiao YY; Yu JM; Fu YH; Zheng YP; Zhu WY; Dong ZJ; He JS
    Virol Sin; 2021 Aug; 36(4):706-720. PubMed ID: 33559831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation.
    Stobart CC; Rostad CA; Ke Z; Dillard RS; Hampton CM; Strauss JD; Yi H; Hotard AL; Meng J; Pickles RJ; Sakamoto K; Lee S; Currier MG; Moin SM; Graham BS; Boukhvalova MS; Gilbert BE; Blanco JC; Piedra PA; Wright ER; Moore ML
    Nat Commun; 2016 Dec; 7():13916. PubMed ID: 28000669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector.
    Martinez-Sobrido L; Gitiban N; Fernandez-Sesma A; Cros J; Mertz SE; Jewell NA; Hammond S; Flano E; Durbin RK; García-Sastre A; Durbin JE
    J Virol; 2006 Feb; 80(3):1130-9. PubMed ID: 16414990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2-2 genes are attenuated in vitro and in vivo.
    Jin H; Zhou H; Cheng X; Tang R; Munoz M; Nguyen N
    Virology; 2000 Jul; 273(1):210-8. PubMed ID: 10891423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.